THURSDAY, April 8, 2021 — Could banning menthol cigarettes be key to lowering smoking rates overall?
New research suggests it’s possible, after finding that a ban on menthol cigarettes in Canada was linked to a large increase in the number of smokers who quit.
The impact of the menthol ban in Canada suggests that a similar ban in the United States would have even greater benefits since menthol cigarettes are much more popular among Americans, the researchers said.
“From our findings, we estimate that banning menthol cigarettes in the U.S. would lead an additional 923,000 smokers to quit, including 230,000 African American smokers,” said researcher Geoffrey Fong. He is a professor of psychology and public health and health systems at the University of Waterloo, in Canada. Fong is also principal investigator of the International Tobacco Control Policy Evaluation Project, based at the university.
In the United States, there’s growing momentum in Congress to enact a national ban on menthol cigarettes, while similar measures are being considered at the state and local levels. At the same time, the U.S. Food and Drug Administration faces a court order to respond to a citizen’s petition to ban menthol cigarettes by April 29, according to The New York Times.
Menthol, the most common flavoring for cigarettes in many countries, reduces the harshness of cigarette smoke. Canada was one of the first countries to ban menthol cigarettes.
To assess the ban’s impact, Fong and his colleagues surveyed nearly 1,100 non-menthol and 138 menthol smokers in 2016 (before the ban) and in 2018 (after the ban).
The researchers found that menthol smokers were much more likely than non-menthol smokers to try to quit after the menthol ban (59% versus 49%), and that daily menthol smokers were nearly two times more likely than daily non-menthol smokers to quit after the menthol ban (21% versus over 11%).
Menthol smokers who had quit smoking before the menthol ban were also significantly less likely than non-menthol smokers who had quit smoking to have started smoking again, according to the study published online April 5 in the journal Tobacco Control.
The ban “did not lead to a high level of illicit menthol cigarette purchasing, which has been a concern by regulators considering a menthol ban,” said Fong, who added that “fewer than 10% of menthol smokers reported still smoking a menthol brand after the ban.”
Scientific reviews conducted by U.S. health experts and the World Health Organization concluded that banning menthol cigarettes would have significant public health benefits.
In the United States, those benefits might be greatest among Black Americans because menthol cigarettes are used by 85% of Black smokers, which is more than 2.8 times higher than among white smokers.
“Our study demonstrates the substantial benefits of banning menthol cigarettes,” Fong said in a university news release. “The enormous success of the Canadian menthol ban makes it even clearer now that the U.S. should finally ban menthol, which the tobacco industry has used for decades to attract new smokers and to keep many of them as customers, especially among the African American community.”
© 2021 HealthDay. All rights reserved.
Posted: April 2021
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022